Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Detemir vs NPH Insulin in Children with Type 1 Diabetes
NCT00435019Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Feb 2007
- Primary completion
- Sep 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 11
01
Overview
A Phase 3 trial of insulin detemir in type 1 diabetes mellitus (T1D), sponsored by Novo Nordisk. Started Feb 2007; status: completed.
02
Drugs
insulin detemir
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00435019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00435019.